Article
Mouse Strain Affects Behavioral and Neuroendocrine Stress Responses Following Administration of Probiotic Lactobacillus rhamnosus JB-1 or Traditional Antidepressant Fluoxetine
8 May 2018
Abstract excerpt
Currently, there is keen interest in the development of alternative therapies in the treatment of depression. Given the explosion of research on the microbiota-gut-brain axis, consideration has turned to the potential of probiotics to improve patient outcomes for those suffering from mood disorders. Here we examine the abilities of a known antidepressant, fluoxetine and the probiotic Lactobacillus rhamnosus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
